![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 9
2021
Kleer-Reiter, N.; Julmi, S.; Feichtner, F.; Waselau, A.-C.; Klose, C.; Wriggers, P.; Maier, H. J. und Meyer-Lindenberg, Andrea
(2021):
Biocompatibility and degradation of the open-pored magnesium scaffolds LAE442 and La2.
In: Biomedical materials, Bd. 16, Nr. 3, 035037
[PDF, 6MB]
Kleer-Reiter, N.; Julmi, S.; Feichtner, F.; Waselau, A-C; Klose, C.; Wriggers, P.; Maier, H. J. und Meyer-Lindenberg, A.
(2021):
Biocompatibility and degradation of the open-pored magnesium scaffolds LAE442 and La2.
In: Biomedical Materials, Bd. 16, Nr. 3, 35037
2020
Witting, L. M.; Waselau, A.-C.; Feichtner, F.; Wurm, L.; Julmi, S.; Klose, C.; Gartzke, A.-K.; Maier, H. J.; Wriggers, P. und Meyer-Lindenberg, A.
(2020):
Influence of coatings on degradation and osseointegration of open porous Mg scaffolds in vivo.
In: Materialia, Bd. 14, 100949
2019
Kleer, N.; Julmi, S.; Gartzke, A. -K.; Augustin, J.; Feichtner, F.; Waselau, A. -C.; Klose, C.; Maier, H. J.; Wriggers, P. und Meyer-Lindenberg, A.
(2019):
Comparison of degradation behaviour and osseointegration of the two magnesium scaffolds, LAE442 and La2, in vivo.
In: Materialia, Bd. 8, UNSP 100436
2013
Haas, M.; Heinemann, V.; Kullmann, F.; Laubender, Rüdiger P.; Klose, C.; Bruns, C. J.; Holdenrieder, S.; Modest, D. P.; Schulz, C. und Boeck, S.
(2013):
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
In: Journal of Cancer Research and Clinical Oncology, Bd. 139, Nr. 4: S. 681-689
2012
Haas, M.; Laubender, Rüdiger P.; Klose, C.; Schulz, C.; Mansmann, Ulrich; Boeck, S. und Heinemann, V.
(2012):
External Validation of 2 Prognostic Indices for Patients With Advanced Pancreatic Cancer Treated With First-line Therapy.
In: Pancreas, Bd. 41, Nr. 5: S. 738-744
2010
Bountogo, M.; Zoungrana, Augustin; Coulibaly, B.; Klose, C.; Mansmann, Ulrich; Mockenhaupt, F. P.; Burhenne, Jürgen; Mikus, Gerd; Walter-Sack, Ingeborg; Schirmer, Heiner; Sie, A.; Meissner, P. und Müller, Olaf
(2010):
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso.
In: Tropical Medicine and International Health, Bd. 15, Nr. 6: S. 713-717
Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Kullmann, F.; Klose, C.; Bruns, C. J.; Wilkowski, R.; Stieber, P.; Holdenrieder, S.; Buchner, Hannes; Mansmann, Ulrich und Heinemann, V.
(2010):
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer.
In: Clinical Cancer Research, Bd. 16, Nr. 3: S. 986-994
2009
Coulibaly, B.; Zoungrana, Augustin; Mockenhaupt, F. P.; Schirmer, Heiner; Klose, C.; Mansmann, Ulrich; Meissner, P. E. und Müller, Olaf
(2009):
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.
In: PLOS ONE 4(5), e5318 [PDF, 190kB]
In: PLOS ONE 4(5), e5318 [PDF, 190kB]